Contents:

Wound Treatments in Turkey Euromonitor International April 2009 List of Contents and Tables Executive Summary State Endeavours To Strengthen Competitive Power of Generics Legislative Changes Slow Introduction of OTC Healthcare Concept Novartis Leads, Followed by Sandoz Pharmacies the Dominant Retail Channel Social Security and General Health Insurance Law Will Lead To Constant Value Decline Over Forecast Period Key Trends and Developments New National Health System Triggers Volume Growth But Constant Unit Prices Decline Private Health Insurances Have Positive Impact Original Patent Time Limits Start To Expire, Number of Generics Increases Increased Number of Pharmacies Could Not Resolve the Distribution Issue Yet OTC Regulations Likely To Be Enacted by 2010 Market Indicators Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008 Table 2 Life Expectancy at Birth 2003-2008 Market Data Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008 Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008 Table 5 OTC Healthcare Company Shares by Value 2004-2008 Table 6 OTC Healthcare Brand Shares by Value 2005-2008 Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008 Table 8 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008 Table 9 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013 Table 10 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013 Appendix OTC Registration and Classification Advertising Packaging and Labelling Distribution De-listing Or De-reimbursement Traditional Remedies Homeopathy Consumer Expenditure on Health Goods and Medical Services Self-medication and Preventative Medicine Generics Switches Definitions Summary 1 Research Sources Abdi Ibrahim Ilaç Sanayi Ve Ticaret As Strategic Direction Key Facts Summary 2 Abdi Ibrahim Ilac Sanayi AS: Key Facts Summary 3 Abdi Ibrahim Ilac Sanayi AS: Operational Indicators 2005-2007 Company Background Production Competitive Positioning Summary 4 Abdi Ibrahim Ilac Sanayi AS: Competitive Position 2008 Bilim Ilac Sanayi Ve Ticaret As Strategic Direction Key Facts Summary 5 Bilim Ilac Sanayi ve Ticaret AS: Key Facts Summary 6 Bilim Ilac Sanayi ve Ticaret AS: Operational Indicators 2005-2007 Company Background Production Competitive Positioning Summary 7 Bilim Ilac Sanayi ve Ticaret AS: Competitive Position 2008 Deva Holding As Strategic Direction Key Facts Summary 8 Deva Holding AS: Key Facts Summary 9 Deva Holding AS: Operational Indicators 2005-2007 Company Background Production Competitive Positioning Summary 10 Deva Holding AS: Competitive Position 2008 Eczacibasi Ilac Sanayi Ve Ticaret As Strategic Direction Key Facts Summary 11 Eczacibasi Ilac Sanayi ve Ticaret AS: Key Facts Summary 12 Eczacibasi Ilac Sanayi ve Ticaret AS: Operational Indicators 2005-2007 Company Background Production Competitive Positioning Summary 13 Eczacibasi Ilac Sanayi ve Ticaret AS: Competitive Position 2008 Nobel Ilac Sanayi Ve Ticaret As Strategic Direction Key Facts Summary 14 Nobel Ilac Sanayi ve Ticaret AS: Key Facts Summary 15 Nobel Ilac Sanayi ve Ticaret AS: Operational Indicators 2005-2007 Company Background Production Competitive Positioning Summary 16 Nobel Ilac Sanayi ve Ticaret AS: Competitive Position 2008 Trends Sector Data Table 11 Sales of Wound Treatments by Subsector: Value 2003-2008 Table 12 Sales of Wound Treatments by Subsector: % Value Growth 2003-2008 Table 13 Wound Treatments Company Shares by Value 2004-2008 Table 14 Wound Treatments Brand Shares by Value 2005-2008 Table 15 Forecast Sales of Wound Treatments by Subsector: Value 2008-2013 Table 16 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2008-2013